Stockreport

Forbion-backed biotech Progentos debuts with $65M for MS drug [Yahoo! Finance]

Korro Bio, Inc.  (KRRO) 
PDF The company, Progentos Therapeutics, has raised $65 million through a Series A financing that also involved Alta Partners, Mission BioCapital, Longwood Fund and Dolby F [Read more]